Calendar

An AMCP Market Insights Webinar.

This webinar will provide an overview of the prevalence, pathology, and disease management of Mucopolysaccharidosis (MPS), a group of ultra-rare inherited metabolic disorders for which there is currently no cure. Panelists will share key insights and findings from AMCP’s Market Insights Roundtable, The Role of Managed Care in Improving Patient Care in Mucopolysaccharidosis.

Rare diseases pose significant challenges for managed care, requiring innovative solutions and a deep understanding of patient needs. Join this virtual event spotlighting four rare diseases. Through discussion of emerging therapies, patient journeys, and managed care strategies, attendees will gain practical insights for improving access, supporting adherence, and advancing equitable care for those affected by rare diseases.

11am-12:15 pm
Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice - Managed Care Insights into Hereditary Angioedema and Beta Thalassemia

2-3:15pm ET
Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice - Managed Care Insights into Myasthenia Gravis and Phenylketonuria

A Pre-Approval Information Exchange (PIE) Webinar, presented by Rhythm Pharmaceuticals, Inc.

Acquired HO is a devastating disease that occurs most frequently after hypothalamic injury resulting from surgical resection or radiation of brain tumors, TBI, or stroke. It is characterized by accelerated weight gain, reduced energy expenditure, and hyperphagia, and it carries significant long-term burdens for patients and their caregivers. This presentation will review efficacy and safety results from a clinical trial evaluating an investigational treatment for acquired HO.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

A Science & Innovation Webinar, presented by Abbvie.

Alopecia Areata is more than a cosmetic hair loss concern. It is a chronic, autoimmune disease characterized by unpredictable, non-scarring hair loss that can affect the scalp, face, and body. While its most visible manifestation is hair loss, AA reflects underlying immune dysregulation that may extend beyond hair loss. If left untreated or poorly managed, AA can be associated with a range of comorbidities—including Systemic Lupus Erythematosus (SLE), vitiligo, and atopic dermatitis. The psychosocial toll of AA, which may include anxiety, depression, PTSD, stress, social stigma, and social withdrawal, compounds the disease burden and can adversely impact patient outcomes and quality of life.

A Pre-Approval Information Exchange (PIE) Webinar, presented by Sanofi.

Join us for an engaging discussion on multiple myeloma treatment and isatuximab subcutaneous administration via on-body injector (Isa SC OBI). We'll explore the key attributes of the Isa SC OBI device, including preparation and administration protocols. The session will review clinical evidence from the IRAKLIA trial demonstrating non-inferiority between Isa IV and Isa SC OBI, as well as findings from the IZALCO trial investigating Isa SC OBI vs. manual push administration.

This webinar is only offered to payers, formulary committees, or other similar entities
responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product has not been established.

A Science & Innovation Webinar, presented by Eisai.

Advances in Alzheimer's disease (AD) diagnostics are reshaping clinical practice, making early and precise detection possible. Explore the latest clinical insights related to blood-based biomarkers, which include their importance in AD and appropriate utilization for patient care.

An AMCP Webinar.

AMCP is launching the Health Disparities LINK, a new member‑driven community created to turn insight into action across managed care pharmacy. Building on the foundational learnings from AMCP’s 2024 Health Disparities Symposium and key reflections from 2025, this kickoff session explores why inequities persist in access, quality, and outcomes—and how themes from “The Education Gap is the Equity Gap: Using Data and SDOH to Empower Smarter Health Decisions: Where Analytics Meet Awareness—and Knowledge Becomes Care” help frame the pathway forward.

This session will highlight how disparities rooted in health literacy, information access, and social determinants of health (SDOH) shape real‑world decision‑making, and how payers can leverage data, analytics, and targeted interventions to promote equitable care and coverage. Attendees will gain insight into the Health Disparities LINK’s 2026 focus areas, early workstreams, and opportunities to contribute case examples, tools, and best practices.

An AMCP Webinar, presented by FormularyDecisions.

Managed care organizations and biopharmaceutical companies today are reimagining how to deliver sustained value and protect future innovation amid significant health policy changes. Key areas that will be covered in this upcoming AMCP webinar will include:

• Mapping the latest policy updates - ranging from manufacturer negotiations on drug pricing to government directives aimed at lowering health insurance costs.
• Forecasting potential future impacts for stakeholders in managed care pharmacy and the biopharmaceutical industry to empower informed decision-making and enhance patient support.
• Sharing real-world insights on how organizations are adapting to current and forecasted policy changes.